Clinical Trial Update: Carboplatin, Pemetrexed Disodium, and Bevacizumab in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating carboplatin, pemetrexed disodium, and bevacizumab in stage IIIB/IV or recurrent non-small cell lung cancer has completed with posted re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• carboplatin, pemetrexed disodium, and bevacizumab

Snippet

Sponsor: Northwestern University | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2019-05-16